Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermolysis Bullosa (EB)”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Early research (Phase 1)Active Not RecruitingNCT06713434
What this trial is testing

Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa

Who this might be right for
Junctional Epidermolysis BullosaEpidermolysis Bullosa (EB)Dystrophic Epidermolysis Bullosa+1 more
Fundación DEBRA Chile, Niños Piel de Cristal 20
Not applicableStudy completedNCT07312513
What this trial is testing

Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds

Who this might be right for
Diabetic UlcersArterial UlcersVenous Ulcers+6 more
Lohmann & Rauscher 100
Testing effectiveness (Phase 2)Study completedNCT02654483
What this trial is testing

Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients

Who this might be right for
Epidermolysis BullosaPruritus
Jean Yuh Tang 14
Post-approval studies (Phase 4)Not Yet RecruitingNCT07717736
What this trial is testing

Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds

Who this might be right for
Epidermolysis Bullosa (EB)Recessive Dystrophic Epidermolysis Bullosa (RDEB)Dystrophic Epidermolysis Bullosa (DEB)
Abeona Therapeutics, Inc 100
Testing effectiveness (Phase 2)Ended earlyNCT03605069
What this trial is testing

A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 Gene

Who this might be right for
Epidermolysis Bullosa Dystrophica, RecessiveEpidermolysis Bullosa Dystrophica, Dominant
Phoenicis Therapeutics 2
Not applicableLooking for participantsNCT07780981
What this trial is testing

Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus Positions

Who this might be right for
DysphagiaEsophageal StrictureEpidermolysis Bullosa (EB)+3 more
Johns Hopkins University 25
Not applicableStudy completedNCT03158662
What this trial is testing

Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Amicus Therapeutics 150
Testing effectiveness (Phase 2)Study completedNCT03529877
What this trial is testing

Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
RHEACELL GmbH & Co. KG 16
Testing effectiveness (Phase 2)Looking for participantsNCT06594393
What this trial is testing

TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

Who this might be right for
Epidermolysis Bullosa (EB)Dystrophic Epidermolysis BullosaJunctional Epidermolysis Bullosa
Xinnate AB 32
Large-scale testing (Phase 3)Active Not RecruitingNCT05464381
What this trial is testing

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

Who this might be right for
Epidermolysis Bullosa
RHEACELL GmbH & Co. KG 91
Testing effectiveness (Phase 2)Looking for participantsNCT06509984
What this trial is testing

A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized

Who this might be right for
Epidermolysis Bullosa SimplexGenodermatosis
Centre Hospitalier Universitaire de Nice 20
Post-approval studies (Phase 4)Active Not RecruitingNCT07596927
What this trial is testing

Curcumin-Based Photodynamic Therapy in Epidermolysis Bullosa: Wound Healing, Quality of Life, and Salivary Biomarkers

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa Acquisita
Universidade Ceuma 20
Testing effectiveness (Phase 2)Looking for participantsNCT06834035
What this trial is testing

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa AcquisitaDystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 8
Large-scale testing (Phase 3)Not Yet RecruitingNCT07482813
What this trial is testing

An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa (EB)
Paradigm Therapeutics 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Emerging Indications for Hyperbaric Oxygen Treatment

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Testing effectiveness (Phase 2)Study completedNCT02582775
What this trial is testing

MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

Who this might be right for
Epidermolysis Bullosa
Masonic Cancer Center, University of Minnesota 17
Testing effectiveness (Phase 2)Study completedNCT03468322
What this trial is testing

A Double-blind, Intra-individual Comparison, POC Trial of AC-203 in EB Patients

Who this might be right for
Inherited Epidermolysis Bullosa
TWi Biotechnology, Inc. 9
Not applicableUnknownNCT05390073
What this trial is testing

Growth Hormone in EB

Who this might be right for
Epidermolysis Bullosa Dystrophica
Cairo University 50
Testing effectiveness (Phase 2)Study completedNCT03389308
What this trial is testing

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa Simplex
Castle Creek Pharmaceuticals, LLC 51
Next Page